Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy

• Published in: Frontiers in oncology Vol. 11; p. 754108
• Main Authors: Cennamo, Gilda, Montorio, Daniela, D' Andrea, Luca, Farella, Antonio, Matano, Elide, Giuliano, Mario, Liuzzi, Raffaele, Breve, Maria Angelica, De Placido, Sabino, Cennamo, Giovanni
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 03.01.2022
• Subjects: complications; local recurrence; metastasis; Oncology; ruthenium-106 brachytherapy; survival rate; uveal melanoma; ruthenium-106 brachytherapy; survival rate; local recurrence; complications; metastasis; uveal melanoma

Uveal melanoma is the most common primary intraocular malignancy. The aim of this retrospective study was to report the results after ruthenium-106 (Ru-106) plaque brachytherapy for uveal melanoma in terms of tumor control, visual acuity, radiation-related complications, tumor recurrence, metastases...